Search for Q&As

Enquirers can use various factors to search for a Q&A:

These include searching by the Q&A ID; legal reference, date submitted, technical standard / guideline, or by keyword if known.
Searches can be extended to more than one legal act, topic, technical standard or guidelines by making multiple selections (i.e. pressing 'Ctrl' on your keyboard, and selecting the relevant ones from the drop-down lists by left mouse-click).

Disclaimer:

Q&As refer to the provisions in force on the day of their publication. The EBA does not systematically review published Q&As following the amendment of legislative acts. Users of the Q&A tool should therefore check the date of publication of the Q&A and whether the provisions referred to in the answer remain the same.

Please note that the Q&As related to the supervisory benchmarking exercises have been moved to the dedicated handbook page. You can submit Q&As on this topic here.

Legal act

Topic

Article

COM Delegated or Implementing Acts/RTS/ITS/GLs/Recommendations

Answer prepared by

Period posted start

Period posted end

Publication start

Publication end

Keywords

Question ID

Final Q&As Q&As under review Rejected Q&As Archived Q&As All Q&As

Export options

Select / deselect all results on this page

List of Q&A's

Calculation of loss given default for fully off-balance exposures in case there are no additional drawings after the default date.

According to point 55 of Article 4(1) of Regulations (EU) No 575/2013 (CRR) ‘Loss given default’ or ‘LGD’ means the ratio of the loss on an exposure due to the default of a counterparty to the amount outstanding at default.   In case the exposure is fully-off balance at the moment of default and there are no additional drawings after default, both the numerator and the denominator of the LGD will be equal to zero. This means that the LGD cannot be calculate using the definition stated above. Should the realized LGD be set equal to zero in this case? 

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Calculation of amount outstanding at default and loss given default for products in scope of Article 166 (10) of Regulations (EU) No 575/2013 (CRR)

Article 181(1)(a) of Regulations (EU) No 575/2013 (CRR) specifies that LGDs shall be estimated on the basis of the average realized LGD by facility grade or pool using all observed defaults. According to point 55 of Article 4(1) of Regulations (EU) No 575/2013 (CRR) ‘Loss given default’ or ‘LGD’ means the ratio of the loss on an exposure due to the default of a counterparty to the amount outstanding at default.   For the purpose of calculating the realized LGD, how should the amount outstanding at default (and the denominator of LGD) be calculated for exposures in scope of Article 166 (10) of Regulations (EU) No 575/2013 (CRR) that are fully off-balance at the moment of default?

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

In the CSRBB framework, the use of a different scope for NII and EVE

In the CSRBB framework, we want to know if banks are allowed use a different scope for NII and EVE.

Legal act: Directive 2013/36/EU (CRD)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Large exposures and guarantee received

Article 400(1)(d) CRR states, among the exemptions from the application of paragraph 1 of Article 395, ‘other exposures (…) guaranteed by central governments (…) where unsecured claims on the entity (…) providing the guarantee would be assigned a 0% risk weight under Part Three, Title II, Chapter 2’. I would like to know whether receiving 0% solvency-weighted securities issued by central governments as collateral makes us fall within the scope of this Article.  In other words, does the fact of receiving such securities as collateral mean that the exposure in question is ‘guaranteed’ by the central government in question under this Article? If so, what are the operational conditions to be met, in particular as regards the maturity of the security vs the maturity of the exposure and as regards any difference in currency between the exposure and the security received as collateral?   L'article 400 1-d du CRR indique, parmi les exemptions à l'application du paragraphe 1 de l'article 395, 'les autres expositions (...) garanties des administrations centrales (...) dès lors qu'une créance non garantie sur l'entité (...) par laquelle elle est garantie recevrait une pondération de risque de 0% en vertu de la troisième partie, titre II, chapitre 2'. Je souhaite savoir si le fait de recevoir en garantie des titres émis par des administrations centrales pondérées à 0% en solvabilité nous fait entrer dans le cadre de cet article.  Autrement dit, le fait de recevoir de tels titres en garantie fail-il que l'exposition en question est 'garantie' par l'administration centrale en question dans le cadre de cet article? Si oui, quelles sont les conditions opérationnelles à respecter, en particulier quant à l'échéance du titre vs l'échéance de l'exposition et quant à une éventuelle différence de devise entre l'exposition et le titre reçu en garantie?

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Deferred tax assets related tax loss due to losses on derivatives in cash flow hedge accounting relationships

In accordance with Article 33(1)(a) CRR, institutions do not include fair value reserves related to gains or losses on cash flow hedges in own funds. Is it correct to also filter deferred tax assets related to the tax loss resulted from fair value reserves related to gains or losses on cash flow hedges?

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Exposure excluded from total exposure measure for the calculation of the leverage ratio

Can the assets that represent funds deposited by a payment institution with the institution, for the fulfilment of its safeguarding obligation under directive 2015/2366 on payment services, be assigned with a risk weight of 0% to the extent they are placed by the institution with a central bank and consequently be excluded from the total exposure measure in accordance with article 429a (1) (c)?

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Treatment of corporate debt securities issued by entities that are set up to raise financing for the parent company or group in the LCR liquid asset buffer

Can corporate debt securities that are issued by entities that are set up to raise financing for the parent company or group be included in the LCR liquid asset buffer, considering that that the main business of this specific entity within the group is the participation of securities issues, which is one of the activities listed in Annex I to Directive 2013/36/EU?

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Delegated Regulation (EU) 2015/61 - DR with regard to liquidity coverage requirement

Calculation of expected credit losses for guaranteed exposures

We would like to know whether full substitution of the guarantor parameters to the debtor’s parameters (so that ECL are effectively calculated on the guarantor) can take place when calculating ECL on a guaranteed exposure in accordance with Regulation 2016/2067 (IFRS 9) as elaborated on by EBA Guidelines 2017/06.

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Capital instruments eligible as Tier 2 Capital

Under the CRR, capital instruments and subordinated loans shall only qualify as Tier 2 instruments provided that the conditions outlined in Article 63 are met. This includes the condition that “the instruments are directly issued by an institution and fully paid up” as per Article 63(a). As further outlined in Annex II instruction to row 0771, such capital instruments also include subordinated loans insofar that they fulfil the eligibility criteria. We would like to request clarification on the eligibility criteria of Article 63(a) in the context of an amendment in the regulation’s text of Article 64, effected via CRR II (Regulation 2019/876). This clarification is sought with the aim of determining whether the “accrued interest” on subordinated debt may be eligible for inclusion as Tier 2 capital, having regard to Article 63(a) and Article 64 in particular.

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2021/451 – ITS on supervisory reporting of institutions

Negative Goodwill

Positive Goodlwill ie where a firm has purchased an entity above book value, is deducted from CET1 to determine the elligible capital balance. However how should Negative Goodwill be treated ie where a firm has purchased an entity at a discount? The profit on the purchase goes through the purchasing firm's P&L so does that mean negative goodwill is elligible to be included in CET1 capital?

Legal act: Directive 2013/36/EU (CRD)
COM Delegated or Implementing Acts/RTS/ITS/GLs: EBA/GL/2016/10 - Guidelines on ICAAP and ILAAP information collected for SREP purposes

Clarification on treatment of repurchase agreements and reverse repurchase agreement, as well as securities lending/borrowing of the banking book and of the trading book under the counterparty credit risk and the treatment of these same transactions under standardised approach of credit risk.

A securities repurchase (repo) is an agreement whereby a transferor agrees to sell securities to a transferee at a specified price and repurchase the securities on a specified date and at a specified price. Since the transaction is regarded as a financing (liability item) of the transferor for accounting purposes, the securities remain on the balance sheet of the transferor. As for the transferee the transaction is treated as a collateralized loan (asset item) for accounting purposes. When referring to “repurchase agreements” in art. 271 CRR, does it applies both to transferor and transferee exposures (in a manner analogous to securities lending transactions on which specific mention to both parties of a transaction –lending and borrowing- is made)? In essence, counterparty credit risk is a bilateral risk, and as such it seems reasonable to capture the risk of both counterparties, even if a transferor and a securities lender will both have accounted the operation as a liability item. Shall the institutions include all repurchase agreements and securities lending/borrowing for counterparty credit risk capital requirements purposes regardless of whether they have been accounted for within the trading or the banking book? According to article 271 (2) an institution shall include the exposure value of repurchase transactions and securities lending/borrowing for counterparty credit risk capital requirements purposes, without making any distinction as to whether they belong to the banking or to the trading book. The exposure value shall be calculated either in accordance with Chapter 4 or Chapter 6 of Title II. However, article 92 (3) (f) states that only SFT transactions of the trading book exposures are subject to counterparty risk capital requirements. Although it could be also interpreted that SFT transactions and agreements of the banking book are also subject to counterparty risk capital requirements according to article 92 (3) (a) as it refers to the whole Title II (including Chapter 6 –counterparty credit risk-). To make things even more confusing, according to article 111 (2) and article 166 (7) the exposure value of any repurchase agreements and securities lending/borrowing shall be included for credit risk capital requirements purposes and it shall be calculated either in accordance with Chapter 4 or Chapter 6. Following the argumentation set out above, the credit risk related to the counterparty in repurchase agreements and securities lending/borrowing of the banking book might be captured twice, once under the standardised approach/IRB method scheme (Chapter 2 or 3) and again under the counterparty credit risk regime (Chapter 6). It does not seem to make sense to ask institutions for capital requirements twice for the same risk concept. Can you please confirm which is the correct treatment for the credit risk related to the counterparty of repurchase agreements and securities lending/borrowing of the banking book? Or do articles 111(2)/116(7) refer to a risk concept different that article 271(2)? Do both parties of a same transaction –transferor and transferee, lender and borrower- have to capture the credit risk related to the counterparty? The same argumentation applies to derivatives, long settlement transactions and marging lending transactions of the banking book.

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Value of domestic payment transactions

Should the value of domestic payments transactions between credit institutions and central banks be considered for this indicator?

Legal act: Directive 2014/59/EU (BRRD)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2019/348 - RTS on simplified obligations for recovery and resolution planning

Calculation of the NPL ratio for determining F_23.00 to F_26.00 reporting requirements

In calculating the ratio outlined in Article 11(g)(ii) of the ITS on Supervisory Reporting to determine applicability of reporting requirements for F_23.00 to F_26.00, should institutions exclude cash balances at central banks and other demand deposits from both numerator and denominator?

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2021/451 – ITS on supervisory reporting of institutions

v11962_m;v11963_m; v11964_m; v11965_m; v11966_m; v11967_m; v11968_m; v11969_m; v11970_m; v11971_m; v11972_m; v11973_m; v11974_m; v11975_m; v11976_m; v11977_m; v11978_m; v11979_m; v11980_m; v11981_m; v11982_m; v11983_m; v11984_m; v11985_m; v11986_m; v11987_m; v11988_m; v11989_m; v11990_m; v11991_m; v11992_m; v11993_m; v11994_m; v11995_m; v11996_m; v11997_m; v11998_m; v11999_m; v12000_m; v12001_m; v12002_m; v12003_m; v12004_m; v12005_m; v12006_m; v12007_m; v12008_m; v12009_m; v12010_m; v12011_m; v12012_m; v12013_m; v12014_m;

Why there is still some validation rules which control if Financial Garantee and Collateral are less than the Gross Carrying Amount in FINREP 19.00?

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

EBA VR v7872_m; v7873_m; v7874_m; v7875_m; v7876_m; v7877_m

Why there is still some validation rules which control if Financial Garantee and Collateral are less than the Gross Carrying Amount in FINREP 18.02?

Legal act: Directive 2013/36/EU (CRD)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Explanation regarding the term "non-reducible"

Could you please explain what does mean the term "nonreducible" in the context of life insurance policy pledged to a lending institution?

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Taxonomy 3.2: Are the validation rules v6327_m and v6332_m consistent?

In Annex II to Regulation (EU) 2021/451, chapter 6.1.2 referring to template C 32.01, the row of the line 0120 “shall correspond to row 0250 of template F 01.01 of Annexes III and IV to this Implementing Regulation”. By this way, the 0120 FAIR VALUE CHANGES OF THE HEDGED ITEMS IN PORTFOLIO HEDGE OF INTEREST RATE RISK may contain negative values. Refer the annex XV of the same implementing regulation, the corresponding validation rules are defined in the taxonomy 3.2 like this: v6327_m: {c0020} <= {c0010} ; Severity: Error v6332_m: {c0090} <= {c0080} ; Severity: Warning However, when the cell C32.01_A0120_0010 is negative, it will be necessary lower than the cell C32.01_A0120_0020 (OF WHICH: TRADING BOOK) and the control v6327_m is wrongly activated. We have the same analysis between the C32.01_A0120_0080 and C32.01_A0120_0090 for the control v6332_m Should these validation rule should be treated in absolute value to be consistent?

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2021/451 – ITS on supervisory reporting of institutions

jiol;ikoio

yhikhujkjh

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Draft ITS on Supervisory Reporting of Institutions

near miss

Hi I am looking for the definition and description of near- miss events and if possible also provide some examples. 

Legal act: Regulation (EU) No 575/2013 (CRR)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Eligibility of communication by AISPs with ASPSP throughout interface used for authentication and communication with the ASPSP's payment services users in case of ASPSP’s exemption from the fall back mechanism

Question no 1:   Does a fact, that based on art. 33(6) RTS, given ASPSP was granted by competent authority with exclusion from the obligation to set up the contingency mechanism described under art. 33(4) RTS, means, that such exemption merely gives this ASPSP a right not to set up the contingency mechanism, and hence, this is up to ASPSP to enjoy and to follow this exclusion, or whether, in opposition, this exemption creates on ASPSP side obligation to bring this exclusion to life.   Question no 2:   Does a fact, that given ASPSP was granted by competent authority with exclusion from the obligation to set up the contingency mechanism described under art. 33(4) RTS, creates on AISP’s end any kind of obligation, for instance lack of right to communicate with ASPSP in question throughout interface made available to the payment service users for the authentication and communication with their ASPSPs.

Legal act: Directive 2015/2366/EU (PSD2)
COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2018/389 - RTS on strong customer authentication and secure communication

Organisation and governance

Legal and policy framework

Careers

Supervisory convergence

Direct supervision and oversight

Information for consumers

Ad hoc activities

Risk analysis

Reporting frameworks

Data

Publications

Media centre